Your browser doesn't support javascript.
loading
Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma: Longitudinal evidence of cognitive awareness from EORTC brain tumour trials.
Caramanna, Ivan; Reijneveld, Jaap C; van de Ven, Peter M; van den Bent, Martin; Idbaih, Ahmed; Wick, Wolfgang; Taphoorn, Martin J B; Dirven, Linda; Bottomley, Andrew; Klein, Martin.
Afiliación
  • Caramanna I; Amsterdam UMC location Vrije Universiteit Amsterdam, Medical Psychology, Amsterdam, The Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Brain Tumor Center, Amsterdam, The Netherlands. Electronic address: i.caramanna@amsterdamumc.nl.
  • Reijneveld JC; Amsterdam UMC location Vrije Universiteit Amsterdam, Brain Tumor Center, Amsterdam, The Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Neurology, Amsterdam, The Netherlands; Department of Neurology, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands. Ele
  • van de Ven PM; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: pven3@umcutrecht.nl.
  • van den Bent M; Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: m.vandenbent@erasmusmc.nl.
  • Idbaih A; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, AP-HP, Hôpital Universitaire La Pitié Salpêtrière, DMU Neurosciences, Paris, France. Electronic address: ahmed.idbaih@aphp.fr.
  • Wick W; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) & Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: wolfgang.wick@med.uni-heidelberg.de.
  • Taphoorn MJB; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands; Department of Neurology, Haaglanden Medical Center, Hague, The Netherlands. Electronic address: M.J.B.Taphoorn@lumc.nl.
  • Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands; Department of Neurology, Haaglanden Medical Center, Hague, The Netherlands. Electronic address: L.Dirven@lumc.nl.
  • Bottomley A; Quality of Life Department, European Organization for Research and Treatment of Cancer, Brussels, Belgium. Electronic address: andrew.bottomley@eortc.org.
  • Klein M; Amsterdam UMC location Vrije Universiteit Amsterdam, Medical Psychology, Amsterdam, The Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Brain Tumor Center, Amsterdam, The Netherlands. Electronic address: m.klein@amsterdamumc.nl.
Eur J Cancer ; 186: 38-51, 2023 06.
Article en En | MEDLINE | ID: mdl-37028200
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioma Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioma Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article